Health Diagnostics

Uri Selome McKakpo of the University of Ghana will develop and test a rapid dipstick test that utilizes monoclonal antibodies to detect parasite antigens present in urine of infected individuals. Using this technology, the team hopes to create a new diagnostic test for malaria that requires minimal training to use and does not depend on invasive blood samples.

Roozbeh Ghaffari, Patrick Beattie, Jason Rolland, and Jeff Carbeck of Diagnostics For All & MC10 Inc. in the U.S. sought to develop disposable paper-based diagnostics devices embedded with optoelectronics, allowing quantitative colorimetric analysis for HIV viral load monitoring. This platform addresses practical limitations of current image capture methodologies and eliminates the need for external readers.

Kevin Plaxco of the University of California, Santa Barbara, United States seeks to develop a diagnostics platform based upon measuring the electric current produced by the binding of antibodies to DNA molecules. If successful, this method will provide a rapid, single-step reagent free measurement of immune antibodies which could significantly augment disease detection and vaccine validation efforts.

Robert Dunn and colleagues at the University of Kansas in the U.S. will develop a diagnostic tool for the early detection of disease that employs writable compact discs that can be read in conventional computer disc drives. Microfluidic structures and immobilized antibodies will be fabricated onto small sections of a compact disc, along with enzymes that produce a reflective "silvering" surface upon recognition of target biomarkers. These changes in reflection can be read by any conventional CD drive, allowing for diagnosis using laptops in low resource settings.

Liaohai Chen of Rush University Medical Center in the U.S. will develop nanoparticles which react to the presence of pathogenic microbes by releasing encapsulated substances that quickly amplify the binding signals. These nanoparticles can be placed on the tip of a litmus strip as a colorimetric assay to indicate the presence and concentration of pathogens.

Vyas Sharma and David Lawrence of the University of North Carolina, Chapel Hill in the U.S. will develop a diagnostic platform based on seed germination by integrating DNA amplification with the expression of reporter proteins in plant seeds to aid in the detection of infectious diseases.

Mark Schnitzer of Stanford University in the U.S. aims to develop miniature microscopes for reliable, low-cost point-of-care diagnosis of tuberculosis. These microscopes will be stand alone, digital diagnostic devices small enough to be carried in a health care provider's pocket or purse and will also be producible in large numbers.

John Fisk of Colorado State University in the U.S. will develop a phage particle that can detect a protein found in urine of active Tuberculosis patients. The two-sided phage particle will detect the presence of the TB protein and also trigger a signal that can be easily detectable.

Joseph Brown of the University of Alabama seeks to develop a low-cost, rapid method to detect pathogenic microbes present in drinking water. Using a filtration system to concentrate bacteria, a tester would add a engineered particles covered in antibodies to detect the presence of pathogens through visual agglutination. The proposed method would take less than 15 minutes to yield a visual result.

Jennifer Doudna of the University of California, Berkeley in the U.S. test the ability of newly discovered RNA restriction enzymes to bind to specific RNA sequences inherent in a wide range of pathogens. If successful, this test could potentially be embedded on wickable paper to test human urine samples and produce a colormetric readout diagnostic like a pregnancy test.